NEW YORK ( TheStreet) -- Electronics manufacturing company Sanmina-SCI (SANM) dropped 17.6% to $11.04 in premarket trading Thursday after cutting its second-quarter earnings forecast to between 28 cents and 32 cents a share, compared with analysts' forecasts of 41 cents a share and the company's previous forecast of 40 cents to 43 cents.
The company said a delay in defense market projects and shipments due to federal budget uncertainty, a recently resolved labor strike in India delaying certain product shipments and short-term softness in the optical market hurt its forecast. Sanmina said that its Chief Operating Officer Hari Pillai is stepping down, but will continue to serve as a consultant.
Novartis (NVS) was rising 1.5% to $53.54 after the New England Journal of Medicine reported that the Xolair asthma drug the drug maker and its peer Roche ( RHHBY ) sells helped cut symptoms in young adults and children.
Financial institutions Bank of America (BAC), Citigroup (C) and UBS (UBS) are all part of a U.S. investigation of the possible manipulation of the London Interbank Offered Rate, The Wall Street Journal reported. Citigroup was up 0.5% to $4.41, Bank of America was up 0.9% to $13.81 and UBS was rising 1% to $18.10 in premarket trading.
Drug developer Abbott Labs (ABT) was rising 0.6% to $47 after DepoMed (DEPO) said in a regulatory filing that it has reached a settlement agreement with the former with regard to Gralise, a once-daily treatment for postherpetic neuralgia. DepoMed was 0.4% higher at $8.71.
Athletic apparel retailer Lululemon Athletica (LULU) was flat at $79.42 after reporting fourth-quarter earnings of 76 cents a share including a tax adjustment, and earnings of 64 cents a share on an adjusted basis, beating expectations of 57 cents a share.
Specialty retailer Guess? (GES) posted an in-line adjusted profit for its fiscal fourth quarter but gave a below-consensus outlook.
>>Search for Highest Dividends by Rate or Yield
|More on Earnings Today's Top Earnings|
>To contact the writer of this article, click here: Andrea Tse. >To follow the writer on Twitter, go to Andrea Tse. >To submit a news tip, send an email to: firstname.lastname@example.org.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV